China Sxt Pharmaceuticals, Inc. (SXTC) — 6-K Filings

6-K Filings (13)

• China SXT Pharmaceuticals Files 6-K with Purchase Agreement — Apr 9, 2026 Risk: low
  China SXT Pharmaceuticals, Inc. filed a Form 6-K on April 9, 2026, reporting its status as a foreign issuer. The filing includes a Securities Purchase Agreement
• China SXT Pharmaceuticals Reports H1 2025 Financials — Dec 31, 2025 Risk: low
  China SXT Pharmaceuticals, Inc. filed a Form 6-K on December 31, 2025, to report its financial results for the six months ended September 30, 2025. The company,
• China SXT Pharmaceuticals Holds Shareholder Meeting — Jul 29, 2025 Risk: low
  China SXT Pharmaceuticals, Inc. held a special shareholder meeting on July 28, 2025, in Taizhou, Jiangsu, China. A total of 39,648,847 ordinary shares were vote
• China SXT Pharmaceuticals Schedules 2025 Special Shareholder Meeting — Jul 15, 2025 Risk: low
  China SXT Pharmaceuticals, Inc. filed a Form 6-K on July 15, 2025, to furnish documents related to its 2025 special meeting of shareholders. The filing includes
• China SXT Pharmaceuticals Sells 10M Shares & Warrants — Jun 16, 2025 Risk: medium
  On May 16, 2025, China SXT Pharmaceuticals, Inc. entered into a securities purchase agreement to sell 10,000,000 ordinary shares and accompanying warrants to se
• China SXT Pharmaceuticals Sells Shares for $100K — May 13, 2025 Risk: medium
  On May 5, 2025, China SXT Pharmaceuticals, Inc. entered into a Securities Purchase Agreement with an investor to sell 200,000 Ordinary Shares. The Company expec
• China SXT Pharmaceuticals Reports H1 2024 Financials — Mar 28, 2025 Risk: low
  China SXT Pharmaceuticals, Inc. filed a Form 6-K on March 28, 2025, to report its unaudited condensed consolidated financial results for the six months ended Se
• China SXT Pharmaceuticals Enters Warrant Exchange Agreement — Mar 19, 2025 Risk: medium
  China SXT Pharmaceuticals, Inc. (SXTC) announced on March 19, 2025, that on March 13, 2025, it entered into a warrant exchange agreement. This agreement involve
• China SXT Pharmaceuticals Sells 14.2M Shares — Jan 27, 2025 Risk: medium
  On January 21, 2025, China SXT Pharmaceuticals, Inc. (SXTC) entered into a securities purchase agreement to sell 14,200,000 ordinary shares to certain individua
• China SXT Pharmaceuticals Director Resigns — Jan 23, 2025 Risk: low
  On January 20, 2025, Songfan He resigned from his positions as an independent director and chairman of the audit committee of China SXT Pharmaceuticals, Inc. He
• China SXT Pharmaceuticals Changes Auditors — Oct 15, 2024 Risk: medium
  China SXT Pharmaceuticals, Inc. announced on October 9, 2024, that its audit committee and board of directors approved the appointment of Enrome LLP as its new
• China SXT Pharmaceuticals Issues $797.5K Promissory Note — May 14, 2024 Risk: medium
  On May 9, 2024, China SXT Pharmaceuticals, Inc. entered into a securities purchase agreement with Streeterville Capital, LLC. As part of this agreement, the com
• China SXT Pharmaceuticals Reports H1 2023 Financials — Apr 5, 2024 Risk: low
  China SXT Pharmaceuticals, Inc. filed a Form 6-K on April 5, 2024, to report its unaudited condensed consolidated financial results for the six months ended Sep

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX